Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |